Jpmorgan Chase & CO Catalyst Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.33 - $0.65 $2,310 - $4,550	7,000 Added 13461.54%	7,052 $3,000
Q2 2023 Aug 11, 2023	BUY	$0.2 - $0.35 $0 - $0	1 Added 1.96%	52 $0
Q2 2022 Aug 11, 2022	SELL	$0.36 - $1.78 $1,091 - $5,395	-3,031 Reduced 98.35%	51 $0
Q1 2022 May 11, 2022	BUY	$0.51 - $1.0 $1,546 - $3,033	3,033 Added 6189.8%	3,082 $2,000
Q4 2021 Feb 10, 2022	SELL	$0.91 - $4.16 $28,262 - $129,201	-31,058 Reduced 99.84%	49 $0
Q3 2021 Nov 12, 2021	BUY	$3.78 - $5.18 $117,584 - $161,134	31,107 New	31,107 $128,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.